Strengthening vaccine-preventable disease prevention and response for period july 1, 2025 - june 30, 2030. - cooperative agreement application strengthening vaccine-preventable disease prevention…

Strengthening vaccine-preventable disease prevention and response for period july 1, 2025 - june 30, 2030. - cooperative agreement application strengthening vaccine-preventable disease prevention and response (CDC RFA-IP-25-0007) project abstract this cooperative agreement application consists of a project narrative, project budget, and all other required forms and documents as outlined in the strengthening vaccine-preventable disease prevention and response notice of funding opportunity (CDC-RFA-IP-25-0007. The purpose of this application is to request continued core federal funding assistance in order to support and maintain the immunization division (IMM), operations which included the implementation of the vaccines for children (VFC) and section 317 vaccine programs. This funding will support alabama's development, implementation, assessment, and promotion of immunization-related activities with the goal of achieving and sustaining high vaccination coverage, reducing vaccination disparities and incidents of vaccine-preventable diseases (VPDS), and improving VPD outbreak readiness and response. The funding will also work to maintain and enhance immunization patient resources with integrated technology (IMMPRINT), the state's immunization information system (IIS). IMM will use collaborative approaches to improve vaccination coverage and increase access to vaccines for alabama residents. IMM will implement strategies in the following seven key areas to achieve successful outcomes in year one (july 1, 2025 - june 30, 2026) and all other subsequent years of the five-year cooperative agreement: 1) strengthen program infrastructure and management; 2) increase vaccine access; 3) improve vaccine equity; 4) promote vaccine confidence and demand; 5) enhance data and evaluation; 6) strengthen program support for partners; and 7) enhance vaccination response readiness. Thank you for your consideration. If you have any questions, please contact me at